7X70
TRIM7 in complex with C-terminal peptide of NSP8
Summary for 7X70
Entry DOI | 10.2210/pdb7x70/pdb |
Descriptor | E3 ubiquitin-protein ligase TRIM7, peptide (3 entities in total) |
Functional Keywords | antiviral protein |
Biological source | Homo sapiens (human) More |
Total number of polymer chains | 2 |
Total formula weight | 20247.98 |
Authors | |
Primary citation | Liang, X.,Xiao, J.,Li, X.,Liu, Y.,Lu, Y.,Wen, Y.,Li, Z.,Che, X.,Ma, Y.,Zhang, X.,Zhang, Y.,Jian, D.,Wang, P.,Xuan, C.,Yu, G.,Li, L.,Zhang, H. A C-terminal glutamine recognition mechanism revealed by E3 ligase TRIM7 structures. Nat.Chem.Biol., 18:1214-1223, 2022 Cited by PubMed Abstract: The E3 ligase TRIM7 has emerged as a critical player in viral infection and pathogenesis. However, the mechanism governing the TRIM7-substrate association remains to be defined. Here we report the crystal structures of TRIM7 in complex with 2C peptides of human enterovirus. Structure-guided studies reveal the C-terminal glutamine residue of 2C as the primary determinant for TRIM7 binding. Leveraged by this finding, we identify norovirus and SARS-CoV-2 proteins, and physiological proteins, as new TRIM7 substrates. Crystal structures of TRIM7 in complex with multiple peptides derived from SARS-CoV-2 proteins display the same glutamine-end recognition mode. Furthermore, TRIM7 could trigger the ubiquitination and degradation of these substrates, possibly representing a new Gln/C-degron pathway. Together, these findings unveil a common recognition mode by TRIM7, providing the foundation for further mechanistic characterization of antiviral and cellular functions of TRIM7. PubMed: 35982226DOI: 10.1038/s41589-022-01128-x PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.25 Å) |
Structure validation
Download full validation report